---
title: Our Approach
description: Our Approach
---

# Our Approach

## Our innovations are brought to life through risk-reward sharing partnerships

##### Our goal is to accelerate and improve the likelihood of our product innovations reaching the global market to enhance patient lives.

Our partnership-enabled business model focuses on forging strategic collaborations with and licensing patented technologies to leading medical device companies to drive successful global commercialization of product candidates we develop. We focus on advancing promising therapeutic solutions, such as AVIM therapy and Virtue SAB, through late-stage clinical research and regulatory approvals, while our partners focus on leveraging their commercial expertise and existing infrastructure to bring our product candidates to global markets quickly and efficiently.

#### Optimizing

development and commercialization of product candidates

#### Enhancing

capital efficiencies by sharing costs and responsibilities with our partners

#### Maximizing

the potential of future profitability by seeking to create multiple long-term royalty and revenue-sharing arrangements with partners

---

## Our key differentiators

#### Partnership

that share responsibilities, risks and rewards

#### Expertise

in therapeutic device development

#### Leadership

in enabling partnerships to drive innovation